# FDA recall D-0474-2026

> **Teva Pharmaceuticals USA, Inc** · Class II · drug recall initiated 2026-03-19.

## Product

Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch

## Reason for recall

CGMP Deviations: use of an unapproved raw material

## Distribution

Within U.S

## Key facts

- **Recall number:** D-0474-2026
- **Recalling firm:** Teva Pharmaceuticals USA, Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-03-19
- **Report date:** 2026-04-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0474-2026

## Citation

> AI Analytics. FDA recall D-0474-2026. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0474-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*